Integrated testing for TB and COVID-19

Emily L. MacLean; Luz Villa-Castillo; Morten Ruhwald; César Ugarte-Gil; Madhukar Pai

doi:10.1016/j.medj.2022.02.002

Integrated testing for TB and COVID-19

Emily L. MacLean
, Luz Villa-Castillo
, Morten Ruhwald
, César Ugarte-Gil
, Madhukar Pai

Facultad de Medicina

McGill University
Research Institute - McGill University Health Centre
Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt
FIND

Producción científica: Contribución a una revista › Comentario/Debate

15 Citas (Scopus)

Resumen

Integrated testing for TB and COVID-19 may help find those TB patients who are not accessing care in the context of the COVID-19 pandemic. Some molecular platforms with assays for both diseases are already commercially available; however, integrated testing approaches need to be systematically evaluated to ensure their appropriate implementation.

Idioma original	Inglés
Páginas (desde-hasta)	162-166
Número de páginas	5
Publicación	Med
Volumen	3
N.º	3
DOI	https://doi.org/10.1016/j.medj.2022.02.002
Estado	Publicada - 11 mar. 2022

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

ODS 3: Salud y bienestar

Acceder al documento

10.1016/j.medj.2022.02.002

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{b17b525519184c1a89a911636f88349c,

title = "Integrated testing for TB and COVID-19",

abstract = "Integrated testing for TB and COVID-19 may help find those TB patients who are not accessing care in the context of the COVID-19 pandemic. Some molecular platforms with assays for both diseases are already commercially available; however, integrated testing approaches need to be systematically evaluated to ensure their appropriate implementation.",

author = "MacLean, \{Emily L.\} and Luz Villa-Castillo and Morten Ruhwald and C{\'e}sar Ugarte-Gil and Madhukar Pai",

note = "Publisher Copyright: {\textcopyright} 2022 Elsevier Inc.",

year = "2022",

month = mar,

day = "11",

doi = "10.1016/j.medj.2022.02.002",

language = "Ingl{\'e}s",

volume = "3",

pages = "162--166",

journal = "Med",

issn = "2666-6359",

number = "3",

}

TY - JOUR

T1 - Integrated testing for TB and COVID-19

AU - MacLean, Emily L.

AU - Villa-Castillo, Luz

AU - Ruhwald, Morten

AU - Ugarte-Gil, César

AU - Pai, Madhukar

PY - 2022/3/11

Y1 - 2022/3/11

N2 - Integrated testing for TB and COVID-19 may help find those TB patients who are not accessing care in the context of the COVID-19 pandemic. Some molecular platforms with assays for both diseases are already commercially available; however, integrated testing approaches need to be systematically evaluated to ensure their appropriate implementation.

AB - Integrated testing for TB and COVID-19 may help find those TB patients who are not accessing care in the context of the COVID-19 pandemic. Some molecular platforms with assays for both diseases are already commercially available; however, integrated testing approaches need to be systematically evaluated to ensure their appropriate implementation.

UR - https://www.scopus.com/pages/publications/85125652773

U2 - 10.1016/j.medj.2022.02.002

DO - 10.1016/j.medj.2022.02.002

M3 - Comentario/Debate

C2 - 35169763

AN - SCOPUS:85125652773

SN - 2666-6359

VL - 3

SP - 162

EP - 166

JO - Med

JF - Med

IS - 3

ER -

Integrated testing for TB and COVID-19

Resumen

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto